GSK’s Tesaro Acquires Alteogen’s ALT-B4
GSK announced on January 20 that its portfolio company, Tesaro, will acquire Alteogen’s novel hyaluronidase enzyme ALT-B4 for $20 million. Alteogen developed ALT-B4 using its bespoke Hybrozyme technology, which the company notes was designed to boost the flexibility and stability of protein structures while preserving the enzyme’s original mechanism of action. Tesaro is a biopharmaceutical company whose major marketed product, Zejula (niraparib), an oral poly ADP ribose polymerase (PARP) inhibitor, is currently approved for use in ovarian cancer. It is owned by GSK. The original press release notes that Tesaro plans to use the tech to develop and potentially market... Read More »
Summit Spine & Joint Centers Acquires Savannah Pain Management and Savannah Pain Center
Summit Spine & Joint Centers, backed by private equity firm Wellspring Capital Management, announced on January 20 that it acquired Savannah Pain Management and Savannah Pain Center. Run by Dr. Keith A. Kirby, MD., Savannah Pain Management and Savannah Pain Center operate as one pain management center with one location in Savannah, Georgia. It also operates one outpatient surgery center. Summit Spine & Joint Centers is a management services organization that provides administrative and support services to its network of clinics and ambulatory surgery centers across the Southeast. It became a portfolio company of Wellspring Capital Management in 2025. This is... Read More »
PE Firm Main Post Partners Buys HomeWell Care Services
HomeWell Care Services announced on January 21 that it has been acquired by San Francisco, California-based Main Post Partners. HomeWell Care Services is a leading national franchise provider of personal care, companionship and homemaker services for seniors and homebound individuals. With locations in 22 states, HomeWell is franchised by HomeWell Franchising Inc. Main Post Partners is a private equity investment firm focused on investing in proven growth companies across the consumer value chain. Main Post Partners invests in both majority and minority positions primarily in first institutional capital situations where founders, entrepreneurs and management teams are looking for a partner... Read More »
KidsChoice Announces Majority Investment from Aquitaine Capital
KidsChoice announced in a January 21 press release that it has received a majority investment from Aquitaine Capital. KidsChoice is an Oklahoma-based provider of clinic-centered autism and pediatric therapy services, serving children and families through applied behavior analysis, speech therapy and occupational therapy. New York City-based Aquitaine Capital is a women-owned private equity firm that partners with founder- and family-owned businesses to support long-term growth. The firm brings capital, operational expertise and a deep network to help management teams scale responsibly while strengthening quality, consistency and performance. Looking ahead, KidsChoice will continue... Read More »
Proactive MD Reports Third Transaction of 2026
On January 16, Proactive MD announced that it acquired undisclosed allergy specialist practices in Virginia. Terms were not disclosed. Proactive MD is a value-based care provider dedicated to transforming healthcare for patients, employers and health plan partners through integrated solutions. Its integrated model offers centralized clinical diagnostics, pathology services, urgent care, pharmacy services and healthcare technology. The company is based in Simpsonville, South Carolina. According to data captured in the LevinPro HC database, this transaction represents the 25th Physician Medical Group acquisition of 2026, and the third in the ear, nose & throat (ENT)... Read More »
GSK Acquires Rapt Therapeutics For $2.2 Billion
In its first transaction of the year, GSK Plc, announced that it acquired Rapt Therapeutics, Inc. for $58 per share. That price equates to an aggregate equity value of $2.2 billion, according to GSK, which added that the upfront investment net of cash acquired comes to $1.9 billion. Net of cash acquired, GSK’s estimated upfront investment is $1.9 billion. Based in South San Francisco, California, RAPT is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients. It develops novel therapies that are designed to modulate the critical immune responses underlying these diseases. According to a... Read More »
Worldwide Clinical Trials to Acquire Catalyst Clinical Research
Worldwide Clinical Trials, a global contract research organization (CRO), announced on January 20 that it will be acquiring Wilmington, North Carolina-headquartered Catalyst Clinical Research, LLC. Financial terms of the deal were not disclosed. Catalyst Clinical Research, LLC is a specialized CRO delivering customizable clinical research solutions to the global biopharmaceutical and biotechnology industries through two established offerings: Catalyst Flex and Catalyst Oncology. With more than 400 staff and offices in the United States and European Union, the company provides multi-therapeutic global resourcing and functional services via Catalyst Flex, alongside a full-service oncology... Read More »
Most Active Physician Group Buyers of 2025
The deal volume in the Physician Medical Group (PMG) sector was strong throughout 2025, totaling 521 transactions, surpassing the 506 reported in 2024. The subsectors with the most activity were dental (248 deals), eye care (34), dermatology (32) and orthopaedic (31). The sector’s year-over-year stability is due to strong competition between investors for consolidation opportunities, high patient demand that goes along with an aging population and the low interest rates announced in 2025 that fueled activity. In 2025, 18 PMG investors reported five or more acquisitions. Private equity-backed groups, fueled by consistent revenue streams and growth opportunities, dominated the M&A... Read More »
ACES Acquires Ally Pediatric Therapy
ACES announced that it is bolstering its services in Arizona with the acquisition of Paradise Valley-based Ally Pediatric Therapy. Founded in 2017, Ally Pediatric Therapy is a leading provider of applied behavior analysis (ABA) therapy and speech-language therapy to children and young adults with autism and other childhood disorders. Ally operates ABA centers across the Phoenix area. ACES, or ACES 2020, LLC, is dedicated to enhancing the quality of life for individuals and families impacted with autism or other special needs. It provides comprehensive, professional services to maximize individuals’ potential in the home, school, clinic and community using accepted teaching and therapeutic... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
